WELCOME to epgonline.org

Welcome to epgonline.org, a free online source of credible and independent scientific content intended for healthcare professionals globally that brings all the medical information you need into one place, providing education and guidance to help with the diagnosis and treatment of your patients.

This website provides:

  • Drug information, categorised using the ATC Classification System, providing indication, dosage, administration and precautions.
  • Specialty and disease information, categorising specialties and diseases using the ICD-10 classification, with further insight found in the Disease Focus area.
  • The Horizons series of articles, written by our team of specialists, that ask what the future of healthcare holds, evaluating emerging trends to provide expert insight.
  • The latest news to keep you up-to-date with current advancements in drug development, advocacy and awareness, industry mergers and acquisitions, clinical trial progression and congress information.
  • Recent opinion articles shared with us by healthcare professionals to express their views and experiences.
  • A wide variety of accredited internal and external CME modules and courses, designed to educate on the latest care strategies for specific conditions.
  • The latest studies, trials and guidelines from global publications provide a comprehensive collection of current and past developments in medicine, helping you to provide best practice.
  • Medical applications that deliver creative solutions to aid in the diagnosis and treatment of your patients.
  • Specialist educational microsites, or Learning Zones, each devoted to self-directed medical education surrounding a specific disease, condition or procedure.

Registration is quick and simple, giving you unlimited access to all content and features, allowing you to save pages, comment on your favourite articles and access the personalised dashboard.

Search Drugs - A-Z

Latest News

Added 19 hours ago Drug news

Complete Response Letter regarding the New Drug Application (NDA) for DUOBRII (IDP-118) lotion in the treatment of plaque psoriasis. - Ortho Dermatologics/Valeant Pharma.

Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. announced that it has received a Complete Response Letter (CRL) from...

Added 19 hours ago Industry news

Stryker may acquire Boston Scientific.

Stryker has made a low key offer to acquire Boston Scientific, which would create a mega corporation with $21.5 billion...


Alex Keen

EULAR 2018 – Biosimilars: the future of rheumatology?

Posted 12 days ago

EULAR's Annual European Congress of Rheumatology aims to encourage innovation and collaboration across all aspects of rheumatology, something that is particularly well illustrated by biologics and their more affordable counterpart, biosimilars. Could they unlock the door to accessible, life-changing treatment for millions more?

Lauren McCracken

EAACI hot topics: Allergen specific immunotherapy (AIT)

Posted 14 days ago

When should AIT be used to treat your patients with allergies? Is it right for every allergy? And do we really know the long-term effects of this treatment? This blog highlights some of the talking points surrounding AIT discussed at this year’s EAACI Congress.

Alex Keen

EAACI 2018 ‒ Allergy management and the smart technology revolution

Posted 28 days ago

The theme of this year’s EAACI congress is ‘innovations for allergy’, so we started thinking what smart technologies, if any, are in development or on the market that could address the allergy epidemic?